SCHEMBL31589467

SCHEMBL31589467

Cc1n[nH]cc1C(=O)N(c1ccc(F)cc1C1CC1)c1ccc([N+](=O)[O-])c2nonc12

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ USP2 O75604 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ S100A4 P26447 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ IDO1 P14902 7/20 0.35
▸ GSTP1 P09211 4/20 0.34
▸ GSTM2 P28161 4/20 0.34
▸ TDO2 P48775 4/20 0.34
▸ MYC P01106 4/20 0.34
▸ MAX P61244 3/20 0.34
▸ NTRK1 P04629 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31589539 0.85 IDO1 (0.45) MEN1KMT2AALDH1A1POLBMAPT
SCHEMBL31589166 0.85 MEN1 (0.40) MEN1KMT2AUSP2ALDH1A1POLB
SCHEMBL31589581 0.85 MEN1 (0.37) MEN1KMT2AUSP2ALDH1A1POLB
SCHEMBL31589923 0.84 KMT2A (0.38) MEN1KMT2AUSP2ALDH1A1POLB
SCHEMBL31590065 0.84 IDO1 (0.43) MEN1KMT2AUSP2ALDH1A1POLB
SCHEMBL31589310 0.84 MEN1 (0.36) MEN1KMT2AUSP2ALDH1A1POLB
SCHEMBL31589361 0.83 IDO1 (0.45) MEN1KMT2AIDO1GSTP1GSTM2
SCHEMBL31589214 0.82 MEN1 (0.41) MEN1KMT2AUSP2ALDH1A1POLB
SCHEMBL31590077 0.82 MEN1 (0.37) MEN1KMT2AUSP2ALDH1A1POLB
SCHEMBL31589894 0.81 IDO1 (0.36) MEN1KMT2AUSP2POLBIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120040371-A Compound capable of degrading MYC in targeted manner and application thereof 中国医学科学院医药生物技术研究所 2025-05-27 — — CN disclosed
Send feedback